FLK-1 is a receptor for vascular endothelial growth factor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 932, 4353201, A61K 4800, C12N 500, C12N 1500

Patent

active

058519998

ABSTRACT:
The present invention relates to the use of ligands for the FLK-1 receptor for the modulation of angiogenesis and vasculogenesis. The invention is based, in part, on the demonstration that Flk-1 tyrosine kinase receptor expression is associated with endothelial cells and the identification of vascular endothelial growth factor (VEGF) as the high affinity ligand of Flk-1. These results indicate a major role for Flk-1 in the signaling system during vasculogenesis and angiogenesis. Engineering of host cells that express Flk-1 and the uses of expressed Flk-1 to evaluate and screen for drugs and analogs of VEGF involved in Flk-1 modulation by either agonist or antagonist activities is described. The invention also relates to the use of FLK-1 ligands, including VEGF agonists and antagonists, in the treatment of disorders, including cancer, by modulating vasculogenesis and angiogenesis.

REFERENCES:
Ueno et al (1991) Science 252: 844-848.
Ueno et al (1992) J. Biol. Chem. 267: 1470-1476.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

FLK-1 is a receptor for vascular endothelial growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with FLK-1 is a receptor for vascular endothelial growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FLK-1 is a receptor for vascular endothelial growth factor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2047779

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.